Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
SSE:600332
Wall Street
Price Targets
Price Targets Summary
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
According to Wall Street analysts, the average 1-year price target for Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd is 32.31 CNY with a low forecast of 23.23 CNY and a high forecast of 44.1 CNY.
Price Targets
Revenue
Forecast
Revenue Estimate
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
For the last 8 years the compound annual growth rate for Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd's revenue is 19%. The projected CAGR for the next 3 years is 4%.
Operating Income
Forecast
Operating Income Estimate
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
For the last 8 years the compound annual growth rate for Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd's operating income is 19%. The projected CAGR for the next 3 years is 4%.
Net Income
Forecast
Net Income Estimate
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
For the last 8 years the compound annual growth rate for Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd's net income is 15%. The projected CAGR for the next 3 years is -11%.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd's stock price target?
Price Target
32.31
CNY
According to Wall Street analysts, the average 1-year price target for Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd is 32.31 CNY with a low forecast of 23.23 CNY and a high forecast of 44.1 CNY.
What is Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd's Revenue forecast?
Projected CAGR
4%
For the last 8 years the compound annual growth rate for Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd's revenue is 19%. The projected CAGR for the next 3 years is 4%.
What is Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd's Operating Income forecast?
Projected CAGR
4%
For the last 8 years the compound annual growth rate for Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd's operating income is 19%. The projected CAGR for the next 3 years is 4%.
What is Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd's Net Income forecast?
Projected CAGR
-11%
For the last 8 years the compound annual growth rate for Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd's net income is 15%. The projected CAGR for the next 3 years is -11%.